BNP PARIBAS ARBITRAGE, SA
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1166588
NEW YORK, NY
Position in SUPN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,910,409
+$3,706,508 QoQ
Shares Held
148,579
+139.7% QoQ
Ownership
0.256%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 335 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BNP PARIBAS ARBITRAGE, SA holds $502,986,525 across 54 Drug Manufacturers - Specialty & Generic names. SUPN ranks #17 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,415,471 | $101,715,746 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
260,605 | $43,922,366 | |
| 3 | RDY |
Dr Reddys Laboratories Ltd
|
2,649,866 | $38,396,558 | |
| 4 | ALKS |
Alkermes plc.
|
655,140 | $34,329,336 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
300,967 | $33,389,278 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
58,580 | $31,740,401 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
1,180,709 | $29,057,248 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
437,192 | $27,958,428 |
All Filings in SUPN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,910,409 | 148,579 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,203,901 | 61,983 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $3,858,211 | 77,630 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $19,865,825 | 415,690 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $9,540,000 | 302,665 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,516,997 | 260,061 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $10,581,464 | 292,629 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,621,520 | 84,077 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,951,466 | 72,952 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,655,804 | 77,860 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $1,546,322 | 53,432 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,083,583 | 39,303 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $406,711 | 13,530 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $906,220 | 25,013 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $614,950 | 17,240 | Shares | Defined | 2023-02-14 | |
| 2022-06-30 | $672,737 | 23,262 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $560,461 | 17,341 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $1,764,763 | 60,520 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,455,648 | 54,580 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $737,512 | 23,953 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $599,862 | 22,913 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $405,076 | 16,100 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $285,549 | 13,702 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $636,547 | 26,802 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $2,264,149 | 125,856 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||